|
102
|
357
|
3v6rA |
Discovery of potent and selective covalent inhibitors of jnk |
|
157
|
566
|
3utoA |
Twitchin kinase region from c.elegans (fn31-nl-kin-crd-ig26) |
|
205
|
639
|
3v5wA |
Human g protein-coupled receptor kinase 2 in complex with soluble gbetagamma subunits and paroxetine |
|
78
|
271
|
3vbyA |
Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in pim-1 kinase needle screening and inhibitor design |
|
123
|
395
|
3v8sA |
Human rho-associated protein kinase 1 (rock 1) in complex with indazole derivative (compound 18) |
|
105
|
357
|
3v6sA |
Discovery of potent and selective covalent inhibitors of jnk |
|
84
|
273
|
3vf8A |
Crystal structure of spleen tyrosine kinase syk catalytic domain with pyrazolylbenzimidazole inhibitor 416 |
|
80
|
274
|
3vc4A |
Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in pim-1 kinase needle screening and inhibitor design |
|
70
|
264
|
3v8tA |
Crystal structure of interleukin-2 inducible t-cell kinase itk catalytic domain with thienopyrazolylindole inhibitor 477 |
|
97
|
357
|
3v3vA |
Structural and functional analysis of quercetagetin, a natural jnk1 inhibitor |
|
79
|
272
|
3vf9A |
Crystal structure of spleen tyrosine kinase syk catalytic domain with thienopyrazolylindole inhibitor 027 |
|
75
|
262
|
3v5lA |
Crystal structure of interleukin-2 inducible t-cell kinase itk catalytic domain with thienopyrazolylindole inhibitor 542 |
|
81
|
322
|
3v04A |
Discovery of novel allosteric mek inhibitors possessing classical and non-classical bidentate ser212 interactions. |
|
157
|
465
|
3v5pA |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1288 |
|
148
|
465
|
3v5tA |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor uw1299 |
|
106
|
348
|
3uvpA |
Human p38 map kinase in complex with a benzamide substituted benzosuberone |
|
103
|
359
|
3vheA |
Crystal structure of human vegfr2 kinase domain with a novel pyrrolopyrimidine inhibitor. |
|
81
|
271
|
3vbvA |
Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in pim-1 kinase needle screening and inhibitor design |
|
65
|
265
|
3v8wA |
Crystal structure of interleukin-2 inducible t-cell kinase itk catalytic domain with thienopyrazolylindole inhibitor 469 |
|
90
|
290
|
3uytA |
Crystal structure of ck1d with pf670462 from p1 crystal form |
|
81
|
271
|
3vbtA |
Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in pim-1 kinase needle screening and inhibitor design |
|
83
|
291
|
3uysA |
Crystal structure of apo human ck1d |
|
88
|
356
|
3vidA |
Crystal structure of human vegfr2 kinase domain with compound a. |
|
76
|
262
|
3vapA |
Synthesis and sar studies of imidazo-[1,2-a]-pyrazine aurora kinase inhibitors with improved off target kinase selectivity |
|
104
|
349
|
3uvqA |
Human p38 map kinase in complex with a dibenzosuberone derivative |
|
85
|
322
|
3v01A |
Discovery of novel allosteric mek inhibitors possessing classical and non-classical bidentate ser212 interactions. |
|
82
|
271
|
3vbxA |
Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in pim-1 kinase needle screening and inhibitor design |
|
161
|
465
|
3v51A |
Calcium-dependent protein kinase 1 from toxoplasma gondii (tgcdpk1) in complex with inhibitor rm-1-176 |
|
79
|
271
|
3vbwA |
Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in pim-1 kinase needle screening and inhibitor design |
|
80
|
271
|
3vbqA |
Exploitation of hydrogen bonding constraints and flat hydrophobic energy landscapes in pim-1 kinase needle screening and inhibitor design |
|
66
|
264
|
3v5jA |
Crystal structure of interleukin-2 inducible t-cell kinase itk catalytic domain with thienopyrazolylindole inhibitor 090 |
|
70
|
264
|
3up7A |
Aurora a in complex with yl1-038-09 |
|
67
|
264
|
3uohA |
Aurora a in complex with rpm1722 |
|
85
|
353
|
3uibA |
Map kinase lmampk10 from leishmania major in complex with sb203580 |
|
77
|
302
|
3uimA |
Structural basis for the impact of phosphorylation on plant receptor-like kinase bak1 activation |
|
89
|
309
|
3uc3A |
The crystal structure of snf1-related kinase 2.3 |
|
87
|
266
|
3uodA |
Aurora a in complex with rpm1693 |
|
79
|
270
|
3ue4A |
Structural and spectroscopic analysis of the kinase inhibitor bosutinib binding to the abl tyrosine kinase domain |
|
103
|
329
|
3u87A |
Structure of a chimeric construct of human ck2alpha and human ck2alpha' in complex with a non-hydrolysable atp-analogue |
|
71
|
264
|
3uo6A |
Aurora a in complex with yl5-083 |
|
85
|
276
|
3uqgA |
C-src kinase domain in complex with bumpless bki analog uw1243 |
|
86
|
322
|
3ug1A |
Crystal structure of the mutated egfr kinase domain (g719s/t790m) in the apo form |
|
95
|
287
|
3ugcA |
Structural basis of jak2 inhibition by the type ii inhibtor nvp-bbt594 |
|
73
|
265
|
3uokA |
Aurora a in complex with yl5-81-1 |
|
78
|
298
|
3uliA |
Human cyclin dependent kinase 2 (cdk2) bound to azabenzimidazole derivative |
|
59
|
288
|
3uiuA |
Crystal structure of apo-pkr kinase domain |
|
78
|
269
|
3uixA |
Crystal structure of pim1 kinase in complex with small molecule inhibitor |
|
103
|
331
|
3u9cA |
Structure of a c-terminal deletion mutant of human protein kinase ck2 catalytic subunit with the atp-competitive inhibitor resorufin |
|
87
|
298
|
3ubdA |
Structure of n-terminal domain of rsk2 kinase in complex with flavonoid glycoside sl0101 |
|
79
|
299
|
3ujgA |
Crystal structure of snrk2.6 in complex with hab1 |
